Ivanova, Elizaveta,
Asadullina, Dilara,
Gilyazova, Gulshat,
Rakhimov, Radmir,
Izmailov, Adel,
Pavlov, Valentin,
Khusnutdinova, Elza,
Gilyazova, Irina (2023) renal cell carcinoma (ccRCC)
treatment. However, the response to therapy among patients
varies greatly
Li, Xiang,
Yin, Lina,
Liao, Jing,
Yang, Jun,
Cai, Binhao,
Yu, Yiming,
Su, Sijia,
Du, Zhiteng,
Li, Xiaobo,
Zhou, Ying,
Chen, Pan,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhang, Fengzhi,
Liang, Guang,
Tang, Qidong (2023) of the compounds by
evaluating their
effect on inhibiting the activity of alkaline phosphatase (ALP) in Hek
Zhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang (2023) the differential
effects and potential target of Sch B. ALI was induced by intratracheal administration of LPS
of sensitivity and specificity. The cost of testing, follow-up procedures, and
treatment for false
Gilyazova, Irina,
Ivanova, Elizaveta,
Sinelnikov, Mikhail,
Pavlov, Valentin,
Khusnutdinova, Elza,
Khusnutdinova, Elza,
Beilerli, Aferin,
Mikhaleva, Ludmila,
Liang, Yanchao (2023) to tumor, node, metastasis (TNM) staging system (p = 0.0256). ROC curve analysis was used to
evaluateGilyazova, Irina,
Asadullina, Dilara,
Kagirova, Evelina,
Sikka, Ruhi,
Mustafin, Artur,
Ivanova, Elizaveta,
Bakhtiyarova, Ksenia,
Gilyazova, Gulshat,
Gupta, Saurabh,
Khusnutdinova, Elza,
Gupta, Himanshu,
Pavlov, Valentin (2023) exerts its
effects is by controlling the expression of certain proteins involved in critical pathways
Agaverdiev, Murad,
Shamsov, Bedil,
Mirzoev, Sorbon,
Vardikyan, Andranik,
Encarnacion, Manuel Ramirez,
Nurmukhametov, Renat,
Beilerli, Aferin,
Zhang, Bohan,
Gareev, Ilgiz,
Pavlov, Valentin (2023) trials have positive results with no serious adverse
effects.
Conclusions: There appears to be a wide